Alterity Therapeutics raises A$20 million in strategic placement

18 hours ago 1

Alterity Therapeutics (NASDAQ:ATHE) on Monday said it has received binding commitments for a capital raising of A$20.0 million of fully paid ordinary shares to International and Australian professional investors.
"The additional funding allows us to continue advancing our clinical and regulatory